M&A / Property
Stock Trend investment Younet partners with Kala

STCQ · Price
Executive Summary
- Stock Trend Capital disclosed that its portfolio company Younet AI entered a strategic partnership with Kala Bio Inc., granting an exclusive worldwide licence to Younet’s AI research platform “Researgency” for biotechnology applications.
- The agreement highlights Younet AI’s progress in commercializing its technology and underscores the strength of Stock Trend’s investment thesis in high‑growth AI businesses.
- Stock Trend Capital indicated it will monitor the partnership closely and provide further updates as material developments arise.
Key Details
- Partnership Announcement Date: March 4, 2026.
- Counterparties: Younet AI (private Canadian AI platform developer) and Kala Bio Inc. (clinical‑stage biopharmaceutical company).
- Agreement Type: Platform development and exclusive licence agreement.
- Scope of Licence: Exclusive worldwide rights for Kala Bio to use Younet’s proprietary AI research platform, internally named “Researgency,” within the biotechnology sector.
- Strategic Rationale: Enables Kala Bio to leverage enterprise‑grade AI for data‑driven drug discovery and development while showcasing Younet’s capability to deliver customized, compliant AI solutions across regulated industries.
- CEO Comment: Anthony Durkacz (CEO, Stock Trend Capital) praised the milestone, noting it validates the firm’s portfolio strategy of backing companies that can translate innovation into commercial traction and may enhance the value of Stock Trend’s investment over time.
- Future Outlook: Stock Trend Capital will continue to work closely with Younet AI and intends to issue additional updates as further material developments occur.
Notable Quotes
“We are pleased to recognize Younet for reaching this milestone and congratulate the team on their execution,” said Anthony Durkacz, chief executive officer of Stock Trend Capital.
“This type of progress is important for Stock Trend because it underscores the strength of our portfolio strategy — identifying companies that can translate innovation into commercial traction.”